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Abstract: Three-dimensional (3D) cell culture systems can be regarded as suitable platforms to
bridge the huge gap between animal studies and two-dimensional (2D) monolayer cell culture
to study chronic diseases such as cancer. In particular, the preclinical platforms for multicellular
spheroid formation and culture can be regarded as ideal in vitro tumour models. The complex
tumour microenvironment such as hypoxic region and necrotic core can be recapitulated in 3D
spheroid configuration. Cells aggregated in spheroid structures can better illustrate the performance
of anti-cancer drugs as well. Various methods have been proposed so far to create such 3D spheroid
aggregations. Both conventional techniques and microfluidic methods can be used for generation
of multicellular spheroids. In this review paper, we first discuss various spheroid formation
phases. Then, the conventional spheroid formation techniques such as bioreactor flasks, liquid
overlay and hanging droplet technique are explained. Next, a particular topic of the hydrogel in
spheroid formation and culture is explored. This topic has received less attention in the literature.
Hydrogels entail some advantages to the spheroid formation and culture such as size uniformity,
the formation of porous spheroids or hetero-spheroids as well as chemosensitivity and invasion
assays and protecting from shear stress. Finally, microfluidic methods for spheroid formation and
culture are briefly reviewed.
Keywords: spheroid culture; microfluidic cell culture; spheroids on-chip; tumour microenvironment;
in vitro cell culture
1. Introduction
A vast number of investigations are being conducted in laboratories and research centres to
produce drugs to cure cancer but few of them can lead to the production of practical and useful drugs.
The main reason of that most probably relates to the procedures utilized for experiments and to the
in vitro platforms for drug screening. As a proof, cancer drug assays in mice, pig and monkeys can
be mentioned, which are predominantly being performed in many laboratories [1]. In fact, these
tests can be beneficial for a general understanding of what happens during the whole process in a
systemic environment but may not be suitable for the drugs that are being generated for human that
have different genotype and phenotype of such animals. Those few drugs that show the effectiveness
of cancer treatment in animal bodies, are used for human clinical trials. Such clinical trials need
complicated protocols and require a large number of cancer patients to take part in the experiment.
In the majority of these experiments, the drug fails to perform the expected task efficiently. Accordingly,
the whole process and investment get wasted and can lead to a significant loss of materials, equipment,
time and money.
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Parallel to what we call animal tests, other types of tests for drug investigation also exist which
are performed using different kinds of methods and equipment. In these methods, cancer cell lines of
human or laboratory animals are used. Although in such platforms the cells belong to human, the
deficiency is the lack of physical and chemical parameters that exist in the tumour microenvironment.
For instance, in an in vivo tumour microenvironment, there is continuous perfusion of oxygen and
nutrients, as well as removal of cellular waste products. However, these features are absent in most
in vitro cancer drug screening platforms such as microwell plates or Petri dishes [2]. This continuous
perfusion and diffusion cause chemical gradients to be made in vivo at tumour sites like hypoxic core
which is essential for realistic in vitro assays.
Tumour microenvironment has several distinctive features [3], Figure 1. First, tumour
microenvironment is hypoxic. Hypoxia occurs as the tumour grows because no capillary has been
generated in tumour yet [4]. The second feature is angiogenesis in which blood vessels are generated
through cancer tumour to deliver oxygen and nutrients to the cells which are proliferating in the
tumour [5]. This phenomenon develops oxygen gradients in the tumour to generate hypoxic and
necrotic regions in it. As the third trait, tumours are composed of different kinds of cells, including
tumour cells, cancer stem cells, fibroblasts, white blood cells (e.g., lymphocytes, macrophages and
neutrophils), fat cells (adipocytes), pericytes and endothelial cells (induced by angiogenesis). So,
it is evident that for a realistic tumour microenvironment, we need to make tumour cultures that are
composed of different types of cells (cell co-culture) as mentioned above. This issue is easy to handle
via microfluidic cell culture chips fabricated by many groups all around the world in the last decade.
Another feature of tumour cancer cells is their tendency of metastasis. Metastasis is a migration of
cancer cells from tumour environment to other places in the body using blood circulation or lymphatic
nodes. The act of crossing the endothelial barrier and entering blood flow is called intravasation. After
entering blood flow, the migratory cancer cell may find a susceptible region to cross the endothelial
barrier and hence diffuse to another organ; this action is extravasation [6].
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Figure 1. Blood vessels, extracellular matrix (ECM) and the tumour cell in the in vivo
tumour microenvironment.
In this paper, we focus most y on the approaches and the platforms that pr vide a 3D environment
for the cancer cells in mono- a d co-cultures. This feature is the most significant f ature of the tumour
environment which dominantly modifies the outcome of the chemotherapy, photodynamic therapy
and so forth on the cancer cells [7–9]. There are a few microfluidic platforms for modelling the
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angiogenesis, cancer cell migration and metastasis which are not the main purpose of this review [10,11].
The three-dimensionality of the tumour cell culture environment has significant effects on tumour
cell responses to cancer drugs due to the cell-cell interactions and the hypoxia condition which take
place only in a three-dimensional (3D) configuration of cells. This fact indicates that monolayer,
two-dimensional (2D) cell cultures (mostly used cultures) are unable to mimic the in vivo behaviour of
cancer cells accurately [12].
The 3D cell culture formation methods have been vastly discussed in the literature but practically,
multiwell plates along with bioreactors and hanging droplet plates have been commercialized and
used by many scientists to form spheroids. Although these approaches have several advantages,
it has been justified that microfluidic devices are capable of forming 3D cell cultures (like spheroids
and hydrogel-based cancer cell encapsulation) and drug tests in high throughput, more efficient and
better-mimicked microenvironments [13]. For instance, the static microenvironment existing in a well
in a microtiter plate causes fast depletion of oxygen and nutrients while increasing waste concentration
in the well. This can influence the spheroid formation and the future results of the drug tests that need
be performed on the tumour [14]. The similarities between in vivo tumour microenvironment and
the tumour spheroids extend further. For instance, the cell proliferation activity in 3D spheroids of
malignant pleural mesothelioma is more similar to that in biopsied cells [15]. Several studies illustrated
that gene expressions were altered in 2D monolayer cancer cell cultures while results obtained from
spheroids captured the in vivo tumour tissue expressions [16] partly as a result of higher production
of the cell adhesion molecules such as E-cadherin. Growth kinetics is also a crucial factor in tumour
spheroids which resembles in vivo tumours [17].
The spheroid culture of cells is not limited to cancer cells. Cell spheroids have been used as 3D
cell cultures for mesenchymal stem cells (MSCs) [18], liver tissue [19], cardiac muscle [20], human
embryonic kidney cells [21] and so forth. Embryonic stem cells, neural stem cells, pancreatic cells and
hepatocytes also need to be cultured in 3D configurations to induce differentiation and express their
own metabolism and proliferation rate similar to the in vivo conditions. Sometimes these cell spheroids
are given different names such as neurospheres or embryoid/organoid body according to their cell
type [22]. Spheroid formation process with these cells is similar to those made of cancerous cells. These
cell spheroids have all the features mentioned above except that some quantities differ among them
including spheroid formation time, oxygen uptake and diffusion and hypoxia limit. For instance,
oxygen diffusion limitations develop necrotic core in both cancerous and hepatic spheroids when the
spheroid grows more than a specified diameter (e.g., 150–200 µm for hepatic cells and 500 µm for
cancerous cells [23]).
Here, first various spheroid formation phases will be introduced. After a brief review of the
conventional spheroid formation techniques, the pros and cons of these methods will be presented.
Next, the effect of hydrogel in spheroid formation and culture will be evaluated. Finally, microfluidic
methods for spheroid formation and culture will be briefly studied.
2. Spheroid Formation Phases
In general, we can divide the spheroid formation process into three phases [24]. Forming cellular
aggregates and making compact spheroids within the first days is called the first phase. Spheroid
diameter decreases during the first phase because cells are attaching to each other and forming stable
aggregates [25], Figure 2A. The duration time of the first phase depends on the cell type as well as
the method used. For example, Torisawa et al. [26] reported that HepG2 cells took three days to
form spheroids, while Michigan Cancer Foundation-7 (MCF-7) cells only took two days on the same
microchip. Chan and colleagues [18] also observed different time durations required for HepG2,
Mesenchymal Stem Cell (MSC), primary mouse embryo fibroblast (PMEF) and Caco-2 cell lines to
form spheroids in a single microfluidic device. Using hanging droplet (HD) method, Kelm et al. [27]
claimed four days for HepG2 and five days for MCF-7 which were much longer than 24 h reported by
those who used microfluidic spheroid formation chips (µSFCs) from the same cell lines [28]. These
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data suggest that spheroid formation time depends strongly on the cell type and is attainable to be
reduced using dynamic flow µSFCs instead of conventional methods with static flow conditions.
It has been reported that not all cell lines can form spheroids or at least have a lower tendency [29].
Increasing the foetal bovine serum (FBS) [30] or reconstituted basement membrane (rBM) [31]
concentration in the culture media can enhance cell aggregation. Hence, it is possible to decrease
spheroid formation duration time by elevating the level of FBS or rBM in the culture media. Frey and
co-workers [30] investigated the effect of FBS concentration on the spheroid formation. The authors
reported that 0% concentration of FBS led to no spheroid formation while the higher concentrations
gave rise to larger spheroids.
In the second phase, spheroids face high proliferation rates and biomass production [32]. Human
colon carcinoma cells (HT-29) continue to proliferate for seven days from the third day [32]. This
phase is reported to be four days (starting from the second day) for human colon carcinoma cells
(HCT116) [24] and lasted up to the fifth day for co-culture of hepatocytes and hepatic stellate cells [33]
on µSFCs. In the third phase, reported by Ziółkowska et al. [32], the spheroid growth and cellular
proliferation slowed down after ten days of culture and spheroid size tended to a constant diameter
(Figure 2(B1)). A similar trend was reported by Lee and co-workers [33] where this phase occurred
from the fifth day onwards for hepatocyte spheroids in accordance with the decrease in spheroid
size. Chen et al. [24] also recorded this phase to begin at the sixth day for human colon carcinoma
cells (HCT116).
After the occurrence of the three phases, the spheroid cells behave as they exist in in vivo
environments. Their proliferation and death obtain a stable condition such that the diameter size does
not grow further while maintaining the viability [24,32] which can be interpreted as homeostasis.
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Figure 2. (A) The figure shows the first phase in which T47D breast cancer cells aggregate to become a
spheroid in 48 h (scale bar: 100 µm) (a–g); A scanning electron microscopy (SEM) of the tumour spheroid
portrays its compactness and roundedness (scale bar: 50 µm) (h). Reproduced with permission from [7]
under a Creative Commons Attribution 4.0 International License from Scientific Reports; (B) HT-29
human carcinoma cell spheroid growth on a chip. (1) The curve shows spheroid total volume with
respect to time while distinguishing spheroid living phases with the colours; (2) A microwell containing
cells for spheroid formation. Reproduced with permission from [32] Copyright © 2012 Elsevier B.V.
3. Conventional Methods for Spheroid For ation
Ther are several methods for cell sph r i f r ti n other than the microfluidic approach
including magnetic levitation [34], 3 -bi i ], hydrophobic surfaces [36], matrix-on-top [37],
matrix-embed ed [38], polymeric a ase system [39], floating liquid marbles [40],
multiwell plates [41], flasks [42], liquid overlay [43] and HD techniques [36]. Some of
these techniques such as HD and multiwell plat s are laborious whil some oth rs like 3D-biopri ting
and magnetic levitation are costly and still lack the standard protocols. A key parameter for cell
spheroid formation is the required time. The bioreactor flasks and the liquid overlay method are very
time-consuming in comparison with others. The other methods such as those utilizing a hydrogel
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matrix and the polymeric aqueous two-phase system are not so common because the required materials
are costly or out of access.
The most important thing is the culture microenvironment of the cell spheroid, not only the
method used for spheroid generation. A question arises here: Are the cell spheroids generated by
these methods cultured in an in vivo-like microenvironment? Maybe it would be easier to form a
cell spheroid and culture it in the same platform afterward. A platform which gives the necessary
conditions for mimicking the in vivo microenvironment for cells would be desired. To find the answer
to the question, we go through the following section in which we describe conventional methods
routinely used for spheroid formation beside discussing their advantages and drawbacks in comparison
with microfluidic techniques. Among the various non-microfluidic methods, the bioreactor flasks,
liquid overlay method and the HD method are chosen to be discussed because of their conventionality,
ease of use and existence of standard protocols.
3.1. Bioreactor Flasks
One of the most high-throughput approaches for spheroid formation and culture is the use of
bioreactors. In this approach, cells are suspended in culture media while being circulated due to the
spinner motion [44] or wall motion [17]. The dynamic environment in the bioreactors is designed to
prevent cell sedimentation and also enhance the stirring of the media and oxygen transfer; meanwhile,
cells are exposed to nutrients in the absence of large concentration gradients. However, these devices
are not suitable for drug screening since they require a high content of drug and culture media and also
cannot mimic the in vivo microenvironment [45]. Thus, for this purpose spheroids must be retrieved
and put into other culture platforms such as the multiwell plates [42] or microfluidic spheroid culture
chips (µSCCs).
In the bioreactor, cell aggregates of various diameters are formed after a given time, depending on
the type of the cell line and the bioreactor physical features such as speed of stirring [42]. Spheroids may
be formed first by other methods and then placed into a bioreactor for culturing [45]. Santo et al. [42]
recently developed an adaptable stirred-tank bioreactor culture strategy to perform high throughput
spheroid formation (HTSF). Agitation frequency or spinner velocity, as well as cell density, are
significant variables in this method of spheroid formation. As reported by Santo et al. [42] and
Nyberg et al. [46] as agitation frequency increased, smaller spheroids were generated. However,
the agitation or stirring rate must be kept above a specific value to hinder cell sedimentation during the
spheroid formation process. Since it is common to culture cell spheroids for long times (e.g., 2 weeks)
in bioreactor flasks, it is crucial to ensure that the shear stress acting on cells in the bioreactor is not
high to affect the study results. Therefore, the spinner design and the circulating frequency should be
adjusted in such a way that the cells have a solid body motion to minimize the shear stress [47].
3.2. Liquid Overlay Method
In this method, a cell suspension is dispensed in a dish or a multiwell plate with non-adherent
bottom surface. This surface is frequently coated with agar or agarose to prevent cell-substrate
attachment [43,48]. Friedrich et al. developed a promising protocol for spheroid-based high throughput
drug screening in which they coated the bottom surface of the wells of multiwell plates with
agarose [48]. PEG (polyethylene glycol) [49] and polystyrene plastic [50] materials are also used
as a non-adherent surface for spheroid formation.
Human cells take one to two days to aggregate. However, not all the cells can generate cell-cell
bindings, meaning that a large number of individual cells exists in addition to the cell aggregates. Thus,
the excess cells should be extracted from the dish by sedimentation separation or other techniques.
A large number of the aggregated cell clusters are not spheroids since some of them have irregular
shapes. After spheroid formation, they are pipetted out from the dish and placed in microwell plates or
bioreactors for long-term culture and drug efficacy tests because the primitive dishes are not suitable
for these purposes [43].
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3.3. Hanging Droplet (HD) Method
One of the best conventional methods for spheroid formation is the HD technique, Figure 3A,B.
In these platforms, highly regular spheroids can be generated in microliter droplets in a short period
of time [27]. Kelm et al. [27] reported that the coefficient of variation (CV) of the spheroid diameter of
HepG2 spheroids made by this method was 10 to 15%, even 5% for MCF-7 spheroids. Comparing these
results with the corresponding values of 40 to 60% for spheroid formation on non-adherent surfaces in
the liquid overlay method signifies the capability of this method in uniform size spheroid formation.
The uniformity and compactness of spheroids made by those cells that exhibit a low tendency of
aggregation such as pancreatic cancer cells, can be improved using methylcellulose in HDs [51].
Tung et al. [52] designed a novel HD platform to ease the procedure being traditionally used
for HD spheroid formation [53]. The platform was compatible with liquid handling robots as
well as conventional plate readers available for 384 & 96-well plates to facilitate high throughput
drug screening. Although these advancements were crucial in spheroid formation, the inherent
characteristics such as static environment, transient oxygen and nutrient concentrations and osmolality
changes due to evaporation confine its ability to mimic the in vivo microenvironments. Liquid
evaporation within the wells and droplets leads to an increase in osmolality that can negatively affect
cell viability [52]. Specific amounts of culture media should be exchanged manually with the delicate
droplets every day to compensate for the evaporated liquid.
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Figure 3. HD methods: (A) conventional HD method implemented in a Petri dish in which droplets
are hanging from the lid; The Image was taken at Sharif Stem Cell Laboratory; (B) HD spheroid
culture in a HD plate: (a) introduction of the cell suspension within the holes; (b) formation of the
droplet by the capillary forces; (c) creation of an HD; (d) cell aggregation; (e) spheroid formation after
one day. Redrawn with permission from [52] Copyright © 2010, Royal Society of Chemistry; (C) a
HD-based µSFC. The figure depicts the pneumatic chamber being pressurized (1) to pr mote the flow
from e central HD to the right HD (2); The left valve which prevente backflow, is now open while
the pneumatic chamber is un essurized (3); Part (4) sh ws the spheroids in the HDs; (5) An image
of the HD based µSFC. Reproduced with permission from [54] Copyright © 2015, Royal Society of
Chemistry; (D) a HD based µSFC integrated with a concentration gradient generator (CGG) whose cell
loading ports are distinct from its drug inlet (a); (b) The image depicts the cell loading channels (using
four colours) and the concentration gradient generated on the chip (using green). Reproduced with
permission from [30] Copyright © 2014, Springer Nature.
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Recently, the deficiency of lacking a dynamic microenvironment in HD platforms has been
solved by novel microfluidic designs [54]. In a valuable work by Yazdi et al. [54], both pulsatile and
steady-state flows were promoted through the device by pneumatic actuation to mimic the in vivo
microenvironment for culturing human cardiac induced pluripotent stem- (iPS)-derived spheroids.
These platforms enabled closed-looped circulation of medium. However, the platform still needed
adding fresh culture medium to compensate the evaporated liquid [30].
4. Hydrogels in Spheroid Culture
In contrast to 2D monolayer as well as 3D hydrogel based cultures, the existence of the natural
extracellular matrix (ECM) between the cells in a spheroid decreases the permeability and the diffusion
rate of drugs and other species of the culture media. As the cell secretions construct the natural
ECM between cells inside a tissue [55], no synthetic or exogenous hydrogels are required to form
tumour spheroids. This effectively reduces the equipment and efforts to have a suitable 3D tumour
microenvironment in contrast to hydrogel-based 3D cultures. The hydrogel-based methods require
gelification, additional materials, for example, CaCl2 (in case of alginate) [56] and equipment such as
hydrogel handling dishes and heating facilities to adjust temperature for crosslinking. However, using
hydrogels entails some advantages to the spheroid formation and culture such as size uniformity [57],
the formation of porous spheroids [58] or hetero-spheroids [59]. Hydrogels can also facilitate
chemosensitivity [60] and invasion assays [61] and can protecting the spheroids from shear stress [18].
Porous spheroids were formed with the goal of increasing nutrient and oxygen exchange [26]
between cells and culture medium by Kojima et al. [19]. To have porous spheroids from hepatoma cell
line (HepG2), 20 µm diameter alginate droplets were generated and added to the cell suspension. After
creating the spheroids using the cell-droplet mixture, the spheroids were made porous by alginate
lyse treatment to remove the alginate from the structure of the spheroids. It was shown that 1 µm
polystyrene particles could enter the central parts while this diffusion was confined only to the few
outer layers of conventional (non-porous) spheroids. Yamada and colleagues [58] generated spheroids
with various mixtures of HepG2 cells and 10 µm collagen microdroplets in 1024 agarose microwells.
They observed that the ratio between the collagen microdroplets and cells influences the hepatic
function characteristics noticeably.
Ota et al. [59] used collagen hydrogels for strengthening the bonding between hepatocyte and
endothelial cells in the spheroids by a coating of 200 nm collagen gel on cells. Collagen gel was also
used for covering hepatocyte spheroids with endothelial cells by coating the hepatocyte spheroids
initially with the collagen gel [62]. As cell-cell adhesions and attachments between non-identical cells
develop slower and weaker [59], collagen gel acts as an anchorage for endothelial cells to stick to the
hepatocyte spheroid preference. In an interesting work, Sabhachandani et al. [63] used alginate as a
hydrogel to encapsulate breast cancer cells (MCF-7) and fibroblast cells to form co-cultured spheroids
in a microfluidic device. Alginate hydrogel permits facile de-crosslinking with the aid of calcium
chelator, therefore, the spheroids can be retrieved for subsequent culture and assays [64].
Placing tumour spheroids in a hydrogel and then crosslinking the gel hinders the dissociation of
the spheroids [18], since the hydrogel plays the role of the in vivo surrounding tissue. However, it can
damage cells on outer layers of spheroid due to the shear stress of the hydrogel itself [18]. Furthermore,
hydrogel protects cells from the shear stress caused by the culture medium flow [65]. Sometimes, cells
are dispensed in hydrogel droplets and anchored in a chip for spheroid formation and assays [66].
5. Microfluidic Methods for Spheroid Culture
Microfluidics is the science and technology of handling a small volume of fluids in the channels
with sub-millimetre length scale [67,68]. As a science and technology, microfluidics can be used for
various fluid mechanics applications, including slip flow in superhydrophobic microchannels [69,70]
and drag reduction [71–73]. In parallel, microfluidic systems hold great promise for cell biology [74],
assisted reproductive technology (ART) [75], drug delivery systems [76], anti-cancer drug screening [77]
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and disease modelling [78]. Recently, microfluidic platforms for spheroid formation and culture have
been thoroughly reviewed by our group [13]. We categorized the µSFCs into two main groups,
which differ in spheroid formation procedure: emulsion-based spheroid formation and; microwell or
U-shaped microstructure-based spheroid formation [13].
Many studies have used flow-focusing droplet generators due to the resultant droplet
and spheroid size uniformity, in addition to their high-throughput continuous operation [79].
Single- [63,80,81], double- [18,82] and triple- [79] emulsion droplet generation techniques have been
used in µSFCs. Axisymmetric [82] or non-axisymmetric [63,79,83] configuration flow-focusing devices
exist. This method facilitates the fast production of microdroplets and thus high-throughput spheroid
formation (HTSF).
Cell-dispensed hydrogel (Gel) in oil (i.e., Gel/O) and cell suspension (CS) in oil (O) (i.e.,
CS/O) [84] droplet generation [63,85] are among the single-emulsion methods which are widely
used. Cell suspension in oil in culture medium (CM) (i.e., CS/O/CM) [18] and CS/Gel/CM [82] are
double-emulsion techniques. Droplet uniformity can be enhanced with CS/Gel/CM double-emulsion
technique which entraps the cells firmly within the droplet. It is facilitated by encapsulating the
cell-containing core droplet within an alginate hydrogel shell [82,86] that acts as an impermeable
barrier with respect to the cells.
Microwells [8,25,87–89] and U-shaped microstructures [21,64,90–93] have been designed for
spheroid formation and culture in microfluidic platforms. These structures facilitate short-term [23,94],
controllable and uniform diameter [22,95] and compact spheroid generation [32,92]. U-shaped
microstructures either are actuated temporarily using pneumatics [91–93,96] or are fixed within
the device [90,93]. A large number of these U-shaped microstructures were embedded (e.g., 360 [92],
28 [64], 512 [97]) in each microchamber of the µSFC to trap the cells [64,90,92,93,96] or the cell dispensed
hydrogel droplets [64] introduced into the chip. Spheroid diameter is confined to the microstructure
size and the relative position of the microstructures is essential for efficient cell trapping. We have
recently evaluated the oxygen and glucose distributions inside spheroids in such bioreactor [98] and
compare the results with those inside toroidal multicellular aggregates [99].
Microwells have been widely utilized inµSFCs due to their simplicity and ease of operation [100–102].
Uniform cell seeding in microwells and uniformly sized spheroids are achieved by filling the device
entirely with the cell suspension before cells begin to enter and trap in the microwells (Figure 4A).
Few minutes are needed that cells deposit on the bottom of the microwells and the microchannel
(Figure 4B). The cells that did not trap in the microwells are pushed out of the chip before the cells
make aggregations and clog microchannels [8,24,103] (Figure 4C). Next, the cells begin aggregation
and form spheroids (Figure 4D) and are culture for drug screening (Figure 4E).
Other works have used acoustic tweezers [104], pyramid microwells [26], porous membranes [105]
and microrotational flow [23] in µSFCs for more efficient spheroid formation. We have recently
shown that electrospinning technique can be efficiently used to fabricate porous membrane [106] and
incorporation of such membrane inside a microchip can give rise to the formation of three different
cellular aggregates, namely, single cells, monolayer and spheroid-like tissue [107].
Spheroids retrieval is required for flow cytometry analysis, stem cell differentiation-assays and
so forth, however, these flow rates might create high shear stress on the spheroids while pushing
them upward [108]. For the real-time on-chip monitoring of the spheroids, several techniques
have been developed including the electrode-based biosensors for oxygen [109], glucose and lactate
concentration [110] and also pH and electrical impedance [111] measurements. These monitoring
techniques alleviate the need for spheroid retrieval from the chip, which effectively reduces the time
and cost.
In designing the µSFCs, the concentration of oxygen and glucose in the culture medium and
the cellular uptake rates should be considered. The complicated geometries of the µSFCs and the
limited diffusion of glucose and oxygen to spheroids create unpredictable concentration profiles within
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the cultured spheroids. Thus, mathematical and numerical analyses combined with experimental
investigations are needed to predict the condition of hypoxia in the spheroids [108,112–116].Inventions 2018, 3, x FOR PEER REVIEW  9 of 20 
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Figure 4. Spheroid formation process in a microwell-based µSFC: (A) Introduction of a cell suspension
to the chip inlet. The cell suspension fills all the microchannels and microwells rapidly due to the
capillary effect; (B) Cells start depositing on the bottom of the microchannels and microwells; (C) Pure
culture medium flows through the chip to rinse the excess cells without disturbing the cells lying on the
microwell bottom; (D) Cell secretions and signalling lead to establishment of cell-cell interactions on
the non-adherent microwell bottom; (E) Driving spheroid formation under a perfusing flow of culture
medium. Reproduced with permission from [13] Copyright © 2018 Elsevier B.V.
The microstructure- or microwell-based µSFCs have limited applications in high-throughput
screening. Various drug concentrations and combinations into a µSFC have rarely been carried out
simultaneously because a suitable microchannel network did not exist. By coupling the µSFC with
a concentration gradient generator chip and arranging the microwells in a configuration compatible
with commercial microplate readers, we can become a step closer to the automated monitoring and
high-t roughput screeni g wit in µSFCs.
The µSCC are designed for spheroid culture and their spheroid com from an external
source. They have been designed with various purposes including shear stress analysis [117], drug
screening [118], multi organ-on-a-chip [119] and analysis of the spheroid fusion process [120]. Digital
microfluidic platforms also are used for spheroid formation and culture [121]. In these devices, the cell
suspension of droplets is directed towards hydrophilic of hanging droplet sites for culturing [122,123].
In this method, continuous flow of the culture medium is limited and sequencing delivery of the
nutrients is performed [124]. In addition, biofouling and liquid evaporation are the drawbacks of
these platforms [125]. The detailed design considerations of µSFCs and µSCCs, such as microstructure
design, shear stress, sph ro d di meter and retrieval me hanis , have been recently reviewed [13].
In Tabl 1, a large number of microfluidic chips are men ioned which were designed for spheroid
formation and culture using various methods. Some critical parameters are reported in the table such
as the cell type, spheroid diameter, spheroid formation time, the flow rate though the microchannels
and so forth which can be very helpful in designing µSFCs and µSCCs.
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Table 1. The table is considered to represent the key variable elements in µSFCs and µSCCs. Those marked with * sign are µSCCs.
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6. Discussion
The conventional methods for spheroid formation have some limitations and disadvantages.
The microfluidic methods have shown the capability in overcoming some of these problems such as
spheroid formation time, size uniformity and shear stress.
The required time in HD plates for spheroid formation is far less than that in spinner flasks.
For instance, Kelm et al. [27] reported 4 days to form HepG2 spheroids while it took 4 to 6 weeks in
spinner flask bioreactors [133]. However, microfluidic platforms appear to facilitate spheroid formation
within a shorter duration of time. Kim et al. [128] showed that spheroid formation took longer in HDs
of MCF-7 breast cancer cells than those in the µSFC. Their results demonstrated that at the second day
of culture, several cell aggregates existed in each HDs while compact spheroids could be observed in
the microwell traps of the µSFC.
As reported by Santo et al. [42], although the spheroids were formed at most on the fourth day in
their stirred-tank bioreactor, large size dispersion existed and appeared to be an inherent feature of
this method.
Ziółkowska et al. observed that the shear stress on cells was higher in a Petri dish when pipetting
the culture media in comparison with the microfluidic culture chip [32]. Kuo et al. reported a size
standard deviation of 104% for on dish liquid overlay and 13% for on-chip spheroid diameters [129].
This illustrated that the spheroid size was much more uniform in the microfluidic approach in
comparison with that in the liquid overlay technique.
7. Conclusions
The complicated spatio-temporal heterogeneity of cancer necessitates novel preclinical models
to be developed for cancer diagnosis and treatment. Among various in vitro models, spheroid
formation and culture has received significant attention due to its tumour-like behaviour. In this
review, we generally categorized the spheroid formation techniques based on two broad groups:
conventional systems and microfluidic platforms. First, we overviewed and compared three different
phases of spheroid formation. The duration of each phase depends largely on the cell type, initial
cell concentration, surface treatment and the employed method. It was found that the duration
of each phase would be shorten in microfluidic systems. Next, we evaluated the non-microfluidic
approaches and discussed the details of three most common conventional techniques, viz., bioreactor
flasks, liquid overlay and hanging droplet. Finally, more novel approaches such as hydrogel-assisted,
emulsion-based and geometrical-based (microwell and U-shape) were briefly discussed.
The three-dimensionality of the tumour cell culture environment has significant effects on tumour
cell responses to cancer drugs due to cell-cell and cell-matrix interactions occurring only in a 3D
configuration of cells. The 3D cell culture formation methods have been vastly discussed in the
literature. However, among these methods multiwell plates, bioreactors and hanging droplet plates
have been commercialized for spheroid formation. Such conventional methods such as hanging
droplets, liquid overlay and non-adherent surfaces and spinner flask methods for tumour spheroid
formation lack the ability to precisely control the number of cells in each spheroid. Therefore, it leads to
spheroids with various diameters. This is cumbersome to separate and group the spheroids. Moreover,
undesired necrotic cores and acidic environments develop. In addition, drug tests are not usually
conclusive on the cells cultured on such platforms. Using these conventional methods also take a lot of
time for spheroid formation and is difficult to achieve cell-cell interactions because cells are not situated
close enough to each other to obtain rapid cell aggregates and spheroids. Furthermore, the shear stress
presenting in roller bottles, suspension culture and pipetting as well as chemical materials, particularly
coating materials (polyethylene glycol (PEG), agarose, agar, etc.), might cause irreversible defects on
cells which usually cannot be quelled. On the other hand, microfluidic devices can form uniform 3D
cell cultures such as spheroids and hydrogel-based cancer cell encapsulation and drug screening can
be used more efficiently and in a high throughput manner.
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